Genetic deletion or pharmacologic inhibition/neutralization of these cytokines and chemokines, such as IL-17, M-CSF, CCL17, and CX3CL1, attenuated PF in experimental models of PF (43, 58–60). The gene discussed is CX3CL1; the disease is pemphigus foliaceus.